跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
陳 達生
Doctor
婦產部
電子郵件
n101389
mail.hosp.ncku.edu
tw
h-index
58
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2017
2024
每年研究成果
概覽
指紋
網路
研究成果
(9)
類似的個人檔案
(6)
指紋
查看啟用 Ta-Sheng Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Adenomyosis
59%
Adverse Outcome
10%
Antepartum Hemorrhage
14%
Assisted Reproduction
29%
Birth Rate
59%
Birth Weight
19%
Blastocyst
14%
Cesarean Section
25%
Clomifene Citrate
59%
Cohort Analysis
59%
Colon Anastomosis
19%
Developmental Stage
10%
Dysmenorrhea
14%
Eclampsia
10%
Eclampsia and Preeclampsia
19%
Embryo Development
23%
Embryo Transfer
31%
Endometriosis
29%
Endometrium Tumor
14%
Fertilization
13%
Gestagen
14%
Gestational Age
25%
Gestational Diabetes
10%
Gestational Hypertension
59%
Gonadorelin Derivative
14%
High-Intensity Focused Ultrasound
59%
In Vitro Fertilisation
66%
International Classification of Diseases
10%
Laparoscopic Surgery
14%
Letrozole
59%
Logistic Regression Analysis
10%
Maternal Age
100%
Menorrhagia
14%
Neonatal Infant
14%
Obstetrics
59%
Odds Ratio
26%
Oocyte
89%
Parental Age
59%
Paternal Age
59%
Placenta Previa
14%
Pre-Eclampsia
65%
Pregnancy Rate
10%
Premature Labor
59%
Prevalence
10%
Quality of Life
14%
Retrospective Cohort Study
10%
Single Embryo Transfer
19%
Spontaneous Abortion
10%
Tocolysis
19%
Twin Pregnancy
44%
Keyphrases
Advanced Paternal Age
7%
Assisted Reproductive Technology
59%
Birth Environment
7%
Birth Outcomes
59%
Birth Weight for Gestational Age
10%
Challenging Situation
19%
Cumulative Live Birth Rate
29%
Decreasing Trend
10%
Deep Infiltrating Endometriosis
29%
Dispersion Measure
6%
Donor Oocyte
44%
First Trimester Miscarriage
14%
Follicular Output Rate
14%
Frozen Embryo Transfer
14%
Gonadotropin-releasing Hormone Analogue Treatment
14%
Halosperm
6%
Ileocolonic Anastomosis
19%
IVF Registry
14%
Low Birth Weight
14%
Metaphase II Oocytes
14%
Mild Ovarian Stimulation
59%
Multiple Births
59%
Perinatal Outcome
59%
Population Attributable Risk
10%
Preterm Birth Risk
19%
Preterm Delivery
14%
Progestin-primed Ovarian Stimulation Protocol
14%
Progressive Motility
6%
Retrieved Oocytes
14%
Safer Conception
14%
Sexual Outcomes
7%
Single Embryo Transfer
14%
Small-for-gestational Age
25%
Sperm Chromatin Structure Assay
40%
Sperm DNA Fragmentation
13%
Sperm DNA Fragmentation Index
59%
Stimulation Cycle
29%
Taiwan
59%
Total Motility
6%
Trends over Time
10%
